UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549


FORM 8-K


CURRENT REPORT

Pursuant to Section 13 OR 15(d) of

The Securities Exchange Act of 1934


Date of Report (Date of Earliest Event Reported):  December 3, 2014


[f8kdec32014locpayoff001.jpg]


N-VIRO INTERNATIONAL CORPORATION

(Exact Name of Registrant as Specified in its Charter)


Delaware

0-21802

34-1741211

(State or Other Jurisdiction of Incorporation or Organization)

(Commission File Number)

(IRS Employer Identification No.)



2254 Centennial Road  Toledo, OH

43617

(Address of principal executive offices)

(Zip Code)


Registrant's telephone number, including area code:    (419) 535-6374


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

[  ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[  ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[  ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[  ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))








Item 1.02 – Termination of a Material Definitive Agreement


On December 3, 2014, N-Viro International Corporation paid the remaining balance owed Monroe Bank + Trust (the “Bank”) on its existing Commercial Line of Credit Agreement, totaling nearly $99,000 with accrued interest.  In conjunction with the Line of Credit, the Company had signed a forbearance agreement with the Bank in April 2014 and was currently in default when it matured in September 2014.  All agreements with the Bank have been satisfied in full, and all existing liens and security held in accordance with the agreements were immediately released.




SIGNATURE


Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


N-VIRO INTERNATIONAL CORPORATION



Dated:

December 10, 2014

By:

  /s/  James K. McHugh

James K. McHugh

Chief Financial Officer



Page 2 of 2